Annual Meeting of the Japanese Society of Toxicology
The 6th International Congress of Asian Society of Toxicology
Session ID : AP-222
Conference information

Others
L-serine attenuate steatosis by suppression of hyperhomocysteinemia
*Woo-Cheol SIMHo-Sung CHOIHu-Quan YINHui Chan KWAKByung-Hoon LEESang Kyum KIM
Author information
CONFERENCE PROCEEDINGS FREE ACCESS

Details
Abstract
Increasing evidence showed that hyperhomocysteinemia plays an important role in the development of steatosis. In this study we evaluated the effects of L-serine (L-ser) on the ethanol-induced steatosis and elucidated the possible mechanisms of action in terms of the inhibition of the maturation of SREBP-1c through suppression of hyperhomocysteinemia. In vitro studies showed that treatment of AML-12 murine hepatocytes with methionine and homocysteine increased the intracellular homocysteine levels and triglyceride contents, whereas cotreatment with L-ser decreased the homocysteine and triglyceride accumulation. L-ser treatment increased the expression of insulin-induced gene-1 (INSIG-1) and inhibited the maturation and translocation of SREBP-1c to the nucleus. Transfection of the cells with siRNA for betaine homocysteine S-methyltransferase (BHMT) or cystathionine beta-synthase (CBS) increased cellular homocysteine and triglyceride level possibly due to the increase in the activation of SREBP-1. L-ser treatment reversed the SREBP-1 activation and triglyceride accumulation in BHMT siRNA-transfected cells, but not in CBS siRNA transfected cells. Male C57BL/6 mice received ethanol (5g/kg body weight) by gavage every 12 hours for a total 3 times. L-ser (200mg/kg body weight) was administrated by gavage for the last two ethanol treatment. L-Ser treatment significantly attenuated hyperhomocysteinemia. Ethanol-induced activation of SREBP-1 and accumulation of triglyceride in the liver were reversed by L-ser. These results demonstrate that L-ser inhibits hyperhomocysteinemia by accelerating the conversion of homocysteine to cystathionine which results in the amelioration of SREBP-1 activation and fatty liver.
Content from these authors
© 2012 The Japanese Society of Toxicology
Previous article Next article
feedback
Top